Infectious Disease and Microbiology – Citrobacter Species

Overview

Citrobacter species are aerobic Gram-negative bacilli that belong to the Enterobacterales and can cause a variety of opportunistic infections. They are increasingly important as healthcare-associated pathogens, particularly in hospitalized, debilitated, or immunocompromised patients.

The major clinically relevant species include Citrobacter freundii, Citrobacter koseri, and Citrobacter amalonaticus. Of particular importance, C. koseri has a strong association with neonatal meningitis and brain abscess formation.

Microbiologic Characteristics

Citrobacter organisms are Gram-negative bacilli and facultative anaerobes within the Enterobacterales.

Important characteristics include:

• Gram-negative rods

• Facultative anaerobic metabolism

• Growth on routine bacterial culture media

• Environmental and gastrointestinal reservoirs

They may colonize the human gastrointestinal tract without producing disease but can become pathogenic when host defenses are impaired or invasive devices are present.

Epidemiology

Citrobacter infections occur worldwide and have become increasingly recognized as causes of nosocomial infection.

Healthcare-associated disease is particularly associated with:

• Prolonged hospitalization

• Intensive care exposure

• Indwelling urinary catheters

• Central venous catheters

• Recent surgery

• Broad-spectrum antibiotic exposure

• Immunocompromised states

Because Citrobacter can colonize the gastrointestinal tract, infections may arise endogenously or through healthcare-associated transmission.

Clinical Infections

Urinary Tract Infection

Urinary tract infection is a common manifestation, particularly in hospitalized patients and those with urinary instrumentation.

Clinical presentations range from:

• Asymptomatic bacteriuria

• Cystitis

• Complicated UTI

• Pyelonephritis

• Urosepsis

Indwelling urinary catheters are an important predisposing factor.

Pulmonary Infection

Citrobacter can occasionally cause pneumonia, particularly in hospitalized or immunocompromised patients.

Manifestations may include:

• Fever

• Productive cough

• Dyspnea

• Hypoxemia

• Pulmonary infiltrates

Healthcare-associated and ventilator-associated infections are particularly relevant.

Catheter-Associated Bacteremia

Central venous and other intravascular catheters may become colonized and produce bloodstream infection.

Patients may develop:

• Fever and chills

• Persistent bacteremia

• Hypotension

• Sepsis or septic shock

Removal of an infected catheter may be necessary in addition to antimicrobial therapy.

Surgical Wound Infection

Citrobacter species can infect postoperative wounds and other disrupted skin or soft-tissue sites.

Clinical manifestations include:

• Erythema

• Swelling

• Pain

• Purulent drainage

• Wound dehiscence

• Fever

Deep infections may require drainage or surgical debridement in addition to antibiotics.

Neonatal Meningitis

One of the most important clinical associations is:

Citrobacter koseri → neonatal meningitis

C. koseri has a distinctive tendency to cause severe central nervous system infection in neonates and young infants.

Clinical manifestations may include:

• Fever or temperature instability

• Poor feeding

• Irritability

• Lethargy

• Seizures

• Bulging fontanelle

• Altered consciousness

Brain Abscess Formation

A particularly important feature of C. koseri neonatal meningitis is its tendency to produce:

Multiple brain abscesses

This propensity distinguishes C. koseri from many other causes of neonatal bacterial meningitis.

Complications can include:

• Cerebritis

• Multiple cerebral abscesses

• Ventriculitis

• Hydrocephalus

• Seizures

• Long-term neurologic impairment

Therefore, neuroimaging is often important when neonatal Citrobacter meningitis is suspected or confirmed.

Diagnosis

Diagnosis is established by culture of the organism from the affected site.

Depending on the clinical syndrome, specimens may include:

• Urine

• Blood

• Cerebrospinal fluid

• Respiratory specimens

• Wound material

• Abscess fluid

Identification should be followed by antimicrobial susceptibility testing, particularly because resistance patterns can vary substantially.

Antimicrobial Resistance

Resistance is an important consideration in Citrobacter infections.

In particular, C. freundii can possess inducible chromosomal AmpC beta-lactamase, which may confer resistance to several beta-lactam antibiotics.

This means that an isolate can sometimes appear initially susceptible to certain cephalosporins but subsequently develop clinically significant resistance during treatment.

Other resistance mechanisms, including extended-spectrum beta-lactamases and carbapenem resistance, may also occur.

Consequently, treatment of serious infection should be based on:

Species identification + susceptibility testing + infection severity and site

Treatment

Historically active antimicrobial classes include:

• Third-generation cephalosporins

• Antipseudomonal penicillins

• Carbapenems

• Fluoroquinolones

• Aztreonam

• Aminoglycosides

However, because resistance patterns have evolved considerably, these agents should not be assumed to be universally active.

Carbapenems

Agents such as:

• Meropenem

• Imipenem

may be appropriate for severe infections caused by susceptible organisms, particularly when significant beta-lactam resistance is present.

Fluoroquinolones

Fluoroquinolones may be effective against susceptible isolates and can be useful for selected infections, particularly when adequate tissue penetration and an oral treatment option are needed.

Aminoglycosides

An aminoglycoside may have activity against susceptible isolates.

Historically, aminoglycosides have sometimes been added to another active agent in severe Citrobacter infection, although combination therapy is not automatically required for every patient.

Source Control

Antibiotics alone may be insufficient when an infected foreign body or localized collection is present.

Management may therefore include:

• Removal of an infected vascular catheter

• Removal or replacement of an infected urinary catheter

• Drainage of abscesses

• Debridement of infected surgical wounds

High-Yield Clinical Pattern

Neonate

• ●

Gram-negative meningitis

• ●

Multiple cerebral abscesses

→ Strongly consider Citrobacter koseri

Hospital-Acquired Pattern

Hospitalized patient

• ●

Urinary or central venous catheter

• ●

Gram-negative UTI or bacteremia

→ Citrobacter species should be included among possible healthcare-associated Enterobacterales.

Exam Essentials

Genus: Citrobacter

Important species: C. freundii, C. koseri, C. amalonaticus

Microbiology: Gram-negative bacilli, Enterobacterales

Epidemiology: Increasingly important healthcare-associated pathogens

Major infections: UTI, pneumonia, catheter-associated bacteremia, surgical wound infection

Classic neonatal pathogen: C. koseri

Classic complication: Neonatal meningitis with multiple brain abscesses

Diagnosis: Culture with antimicrobial susceptibility testing

Important resistance mechanism: C. freundii may express AmpC beta-lactamase

Potential treatments: Selected according to susceptibility; options may include carbapenems, fluoroquinolones, and other active Gram-negative agents

Source control: Remove infected devices and drain collections when indicated

Key clinical pearl: The association most worth remembering is Citrobacter koseri → neonatal meningitis → multiple brain abscesses, while C. freundii is particularly important for its potential AmpC-mediated antimicrobial resistance.